Tenaya Therapeutics, Inc. (TNYA) News

Tenaya Therapeutics, Inc. (TNYA): $5.30

-0.43 (-7.50%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

Add TNYA to Watchlist
Sign Up

Industry: Biotech


Ranked

of 402

in industry

Filter TNYA News Items

TNYA News Results

Date Symbol Company Title Start End Change POWR Rating
Loading, please wait...

Latest TNYA News From Around the Web

Below are the latest news stories about Tenaya Therapeutics Inc that investors may wish to consider to help them evaluate TNYA as an investment opportunity.

Why Earnings Season Could Be Great for Tenaya Therapeutics (TNYA)

Tenaya Therapeutics (TNYA) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.

Yahoo | February 8, 2022

What Is The Ownership Structure Like For Tenaya Therapeutics, Inc. (NASDAQ:TNYA)?

The big shareholder groups in Tenaya Therapeutics, Inc. ( NASDAQ:TNYA ) have power over the company. Large companies...

Yahoo | February 4, 2022

Tenaya Therapeutics to Participate in Upcoming Investor Conferences

SOUTH SAN FRANCISCO, Calif., January 31, 2022--Tenaya Therapeutics today announced participation at several upcoming investor conferences.

Yahoo | January 31, 2022

Tenaya Therapeutics Provides 2022 Business Updates

SOUTH SAN FRANCISCO, Calif., January 10, 2022--Tenaya Therapeutics provided a 2022 business update.

Yahoo | January 10, 2022

Tenaya Therapeutics (NASDAQ:TNYA) Trading 7.7% Higher

Tenaya Therapeutics Inc (NASDAQ:TNYA)s stock price traded up 7.7% during mid-day trading on Wednesday . The company traded as high as $20.74 and last traded at $20.74. 702 shares changed hands during trading, a decline of 100% from the average session volume of 171,013 shares. The stock had previously closed at $19.26. Separately, Zacks Investment []

Dakota Financial News | December 24, 2021

Rtw Investments, Lp Buys Thermo Fisher Scientific Inc, Penumbra Inc, Tenaya Therapeutics Inc, ...

Investment company Rtw Investments, Lp (Current Portfolio) buys Thermo Fisher Scientific Inc, Penumbra Inc, Tenaya Therapeutics Inc, argenx SE, Macrogenics Inc, sells Quidel Corp, Protagonist Therapeutics Inc, MiMedx Group Inc, , Castle Biosciences Inc during the 3-months ended 2021Q3, according to the most recent filings of the investment company, Rtw Investments, Lp.

Yahoo | December 23, 2021

Tenaya Therapeutics Appoints Karah Parschauer, J.D., to Its Board of Directors and Joanna Auch as Senior Vice President of People and Culture

SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Tenaya Therapeutics, Inc. announces the appointments of Karah Parschauer to its Board of Directors and of Joanna Auch as SVP of People and Culture.

Business Wire | December 22, 2021

Tenaya Therapeutics (NASDAQ:TNYA) and Neurocrine Biosciences (NASDAQ:NBIX) Critical Contrast

Tenaya Therapeutics (NASDAQ:TNYA) and Neurocrine Biosciences (NASDAQ:NBIX) are both medical companies, but which is the superior business? We will compare the two companies based on the strength of their dividends, earnings, institutional ownership, risk, profitability, valuation and analyst recommendations. Insider and Institutional Ownership 34.7% of Tenaya Therapeutics shares are held by institutional investors. Comparatively, 95.3% []

Transcript Daily | December 19, 2021

Harvard University Stock Portfolio: 8 Latest Stock Picks

In this article, we discuss the 8 latest picks in Harvard University’s stock portfolio. You can skip our detailed analysis of the Harvard Management Company’s history and past performance, and go directly to Harvard University Stock Portfolio: 5 Latest Stock Picks. Managing the largest academic endowment in the world, valued at $53.2 billion and comprised […]

Yahoo | December 17, 2021

Tenaya Therapeutics (NASDAQ:TNYA) Shares Gap Up to $18.69

Tenaya Therapeutics Inc (NASDAQ:TNYA)s share price gapped up prior to trading on Tuesday . The stock had previously closed at $18.69, but opened at $19.49. Tenaya Therapeutics shares last traded at $19.61, with a volume of 79 shares changing hands. Several analysts have recently weighed in on the company. Chardan Capital assumed coverage on Tenaya []

Dakota Financial News | November 30, 2021


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!




Page generated in 0.5583 seconds.